Items where Author is "Bai, P."
Group by: Item Type | No Grouping Jump to: Journal article Number of items: 5.
Journal articleMabley, J.G., Pacher, P., Bai, P., Wallace, R., Goonesekera, S., Virag, L., Southan, G.J. and Szabo, C. (2004) Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways Mutation research - fundamental and molecular mechanisms of mutagenesis, 548 (1-2). pp. 107-116. ISSN 0027-5107 Virag, L., Bai, P., Bak, I., Pacher, P., Mabley, J.G., Liaudet, L., Bakondl, E. and Gergely, P. (2004) Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma Medical science monitor, 10 (3). pp. 77-83. ISSN 1643-3750 Bai, P., Mabley, J.G., Liaudet, L., Virag, L., Szabo, C. and Pacher, P. (2004) Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity Oncology reports, 11 . pp. 505-508. ISSN 1021-335X Pacher, P., Liaudet, L., Bai, P., Mabley, J.G., Kaminski, P.M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M.S., Groves, J.T. and Szabo, C. (2003) Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction Circulation, 107 (6). pp. 896-904. ISSN 1524-4539 Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J.G., Hasko, G. and Szabo, C. (2002) Activation of poly(ADP-Ribose) polymerase contributes to development of doxorubicin-induced heart failure Journal of pharmacology and experimental therapeutics, 300 (3). pp. 862-867. ISSN 1521-0103 |

